When the US Food and Drug Administration scheduled a June in-person meeting of its ophthalmic devices panel it seemed to indicate that the agency was hoping to get back to some form of normalcy by then. However, due to the ongoing coronavirus crisis it has now postponed the meeting until further notice.
No End In Sight: FDA Postpones Another In-Person Meeting Due To COVID-19
The US agency had planned to hold an in-person meeting of its ophthalmic advisory committee in early June, indicating hope that things would be back to some form of normal by then. But due to the ongoing coronavirus pandemic, it has postponed that meeting until further notice.
